NLR Revenue and Competitors
Employee Data
- NLR has 60 Employees.
- NLR grew their employee count by 5% last year.
NLR's People
| Name | Title | Email/Phone |
|---|
NLR Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.5M | 152 | 6% | N/A | N/A |
#2 | $7.5M | 42 | -41% | N/A | N/A |
#3 | $3.5M | 98 | 17% | N/A | N/A |
#4 | $7.5M | 91 | 2% | N/A | N/A |
#5 | $7.5M | 72 | 7% | N/A | N/A |
#6 | N/A | 116 | 8% | N/A | N/A |
#7 | $7.5M | 87 | 4% | N/A | N/A |
#8 | $7.5M | 139 | 1% | N/A | N/A |
#9 | $7.5M | 163 | 7% | N/A | N/A |
#10 | $3.5M | 43 | -12% | N/A | N/A |
What Is NLR?
Leprosy still ruins millions of lives. It's a bacterial disease that can be treated and prevented. For centuries, it was seen as a punishment. Since then, numerous medical and social breakthroughs have been made. And yet, the impact of having leprosy is still incredibly high. In the past 50 years, we have been one of the major change-makers. We take pride in enabling research and driving evidence-based innovation. We are known as people who are passionate about stopping leprosy. People who keep going until breakthroughs are ready to be implemented. We continue until No Leprosy Remains.
keywords:N/A
N/A
Total Funding
60
Number of Employees
N/A
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NLR News
A late night visit from a small mammal strolling the streets of North Little Rock is nothing unusual in a suburban neighborhood.
NLR scares. Arkansas improved to 10-1 in games played at Dickey-Stephens Park, but the record doesn't tell the full story of the Razorbacks'...
However, a high NLR was not associated with OS or CSS when researchers looked only at patients with HPV-associated head and neck cancers.
Other Companies in Amsterdam
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 60 | 25% | N/A |
#2 | N/A | 60 | 20% | N/A |
#3 | $13.1M | 60 | 28% | N/A |
#4 | $11.3M | 60 | 15% | N/A |
#5 | $11.3M | 60 | 58% | N/A |